Search: onr:"swepub:oai:DiVA.org:liu-150594" >
Intralymphatic alle...
Intralymphatic allergen immunotherapy against pollen allergy. A 3-year open follow-up study of 10 patients
-
- Ahlbeck, Lars, 1964- (author)
- Linköpings universitet,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten,Region Östergötland, Allergicentrum US
-
- Ahlberg, Emelie (author)
- Linköpings universitet,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten
-
- Nyström Kronander, Ulla, 1957- (author)
- Linköpings universitet,Institutionen för klinisk och experimentell medicin,Medicinska fakulteten,Region Östergötland, Allergicentrum US
-
show more...
-
- Björkander, Janne (author)
- Futurum, Academy of Health and Care, Jönköping, Sweden
-
- Jenmalm, Maria, 1971- (author)
- Linköpings universitet,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten
-
show less...
-
(creator_code:org_t)
- Elsevier, 2018
- 2018
- English.
-
In: Annals of Allergy, Asthma & Immunology. - : Elsevier. - 1081-1206 .- 1534-4436. ; 121:5, s. 626-627
- Related links:
-
https://liu.diva-por... (primary) (Raw object)
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- To date, allergen immunotherapy (AIT) is the only treatment that affects the long-term development of allergic rhinoconjunctivitis and induces clinical tolerance primarily by stimulating regulatory T (Treg) cells, attenuating T helper 2 (Th2) responses and synthesis of blocking antibodies1. Conventional AIT with subcutaneous injections, sublingual tablets or drops is effective, but consumes time and resources 2.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Keyword
- Immunotherapy
- Intralymphatic
- Allergy
- Rhinoconjunctivitis
- T-cells
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database